These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 8839848)

  • 21. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
    Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
    Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of two mutations (Arg611Cys and Arg611His) in the A1 loop of von Willebrand factor (vWF) responsible for type 2 von Willebrand disease with decreased platelet-dependent function of vWF.
    Hilbert L; Gaucher C; Mazurier C
    Blood; 1995 Aug; 86(3):1010-8. PubMed ID: 7620154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of recombinant von Willebrand factor corresponding to mutations in type IIA and type IIB von Willebrand disease.
    Ribba AS; Voorberg J; Meyer D; Pannekoek H; Pietu G
    J Biol Chem; 1992 Nov; 267(32):23209-15. PubMed ID: 1429668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discrepancy between IIA phenotype and IIB genotype in a patient with a variant of von Willebrand disease.
    Ribba AS; Christophe O; Derlon A; Cherel G; Siguret V; Lavergne JM; Girma JP; Meyer D; Pietu G
    Blood; 1994 Feb; 83(3):833-41. PubMed ID: 8298143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant von Willebrand factor Arg578-->Gln. A type IIB von Willebrand disease mutation affects binding to glycoprotein Ib but not to collagen or heparin.
    Randi AM; Jorieux S; Tuley EA; Mazurier C; Sadler JE
    J Biol Chem; 1992 Oct; 267(29):21187-92. PubMed ID: 1400429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor.
    Inbal A; Kornbrot N; Harrison P; Randi AM; Sadler JE
    Thromb Haemost; 1993 Dec; 70(6):1058-62. PubMed ID: 8165601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease.
    Schneppenheim R; Budde U; Obser T; Brassard J; Mainusch K; Ruggeri ZM; Schneppenheim S; Schwaab R; Oldenburg J
    Blood; 2001 Apr; 97(7):2059-66. PubMed ID: 11264172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shielding the front-strand beta 3 of the von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein Ibalpha.
    Bonnefoy A; Yamamoto H; Thys C; Kito M; Vermylen J; Hoylaerts MF
    Blood; 2003 Feb; 101(4):1375-83. PubMed ID: 12393553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.
    Flood VH; Gill JC; Morateck PA; Christopherson PA; Friedman KD; Haberichter SL; Hoffmann RG; Montgomery RR
    Blood; 2011 Feb; 117(6):e67-74. PubMed ID: 21148813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new L1446P mutation is responsible for impaired von Willebrand factor synthesis, structure, and function.
    Casonato A; Cattini MG; Soldera C; Marcato S; Sartorello F; Pontara E; Pagnan A
    J Lab Clin Med; 2004 Nov; 144(5):254-9. PubMed ID: 15570243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A monoclonal antibody (B724) to von Willebrand factor recognizing an epitope within the A1 disulphide loop (Cys509-Cys695) discriminates between type 2A and type 2B von Willebrand disease.
    Christophe O; Rouault C; Obert B; Piétu G; Meyer D; Girma JP
    Br J Haematol; 1995 May; 90(1):195-203. PubMed ID: 7540413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of recombinant von Willebrand factor reproducing type 2B or type 2M mutations on shear-induced platelet aggregation.
    Ajzenberg N; Ribba AS; Rastegar-Lari G; Meyer D; Baruch D
    Blood; 2000 Jun; 95(12):3796-803. PubMed ID: 10845912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
    Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New variant of von Willebrand disease type II with markedly increased levels of von Willebrand factor antigen and dominant mode of inheritance: von Willebrand disease type IIC Miami.
    Ledford MR; Rabinowitz I; Sadler JE; Kent JW; Civantos F
    Blood; 1993 Jul; 82(1):169-75. PubMed ID: 8324222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a novel point mutation in platelet glycoprotein Ibalpha, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease.
    Matsubara Y; Murata M; Sugita K; Ikeda Y
    J Thromb Haemost; 2003 Oct; 1(10):2198-205. PubMed ID: 14521605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers.
    Weiss HJ; Sussman II
    Blood; 1986 Jul; 68(1):149-56. PubMed ID: 3487353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability in platelet- and collagen-binding defects in type 2M von Willebrand disease.
    Larsen DM; Haberichter SL; Gill JC; Shapiro AD; Flood VH
    Haemophilia; 2013 Jul; 19(4):590-4. PubMed ID: 23496210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leu 697-->Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease.
    Hilbert L; Gaucher C; de Romeuf C; Horellou MH; Vink T; Mazurier C
    Blood; 1994 Mar; 83(6):1542-50. PubMed ID: 8123843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetics of von Willebrand disease.
    Mazurier C; Ribba AS; Gaucher C; Meyer D
    Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A probable double heterozygous type II von Willebrand's disease with increased ristocetin induced platelet aggregation.
    Kinoshita S; Yoshioka K; Kasahara M; Takamiya O
    Am J Hematol; 1992 Jul; 40(3):192-8. PubMed ID: 1609773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.